首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Tumor-to-nipple Distance Should Not Preclude Nipple-sparing Mastectomy in Breast Cancer Patients. Personal Experience and Literature Review
【24h】

Tumor-to-nipple Distance Should Not Preclude Nipple-sparing Mastectomy in Breast Cancer Patients. Personal Experience and Literature Review

机译:肿瘤到乳头距离不应排除乳腺癌患者的乳头缓解乳房切除术。 个人经验和文献综述

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aim: A retrospective study was performed in 246 breast cancer patients to define whether tumor-to-nipple distance (TND) assessment by breast MRI may select patients eligible to nipple-sparing mastectomy (NSM) as compared to permanent section assessment of retroareolar margin. Patients and Methods: Pre- and postoperative parameters including imaging data, histology of the primary tumor, biologic prognostic factors, and adjuvant regimens were retrieved; patients with close/positive retroareolar margins underwent nipple or NAC excision. The primary endpoint was loco-regional recurrence (LRR). Results: Patients with TND <= 2 cm had a significantly higher rate of invasive ductal carcinoma (p<0.003) and excision margins less than 2 mm (p<0.000). Eleven retroareolar specimens were positive at definitive pathology; final re-excision specimen examination showed residual disease in seven patients (63.6%). At a median follow-up of 31 to 33 months, no NAC recurrence did occur; disease-free survival was more than 96%, and LRR was homogeneously distributed among TND subgroups. Conclusion: Therapeutic NSM is a safe procedure independently of TND assessed at preoperative breast MRI. Permanent section assessment of retroareolar tissue is more accurate and cost-effective than frozen section. Furthermore, delayed nipple and/or NAC excision did not impair local disease control.
机译:背景/目的:在246例乳腺癌患者中进行了回顾性研究,以定义乳腺MRI的肿瘤到乳头距离(TND)评估是否可以选择患者与Retroareolar的永久部分评估相比,患有有资格的乳化乳腺切除术(NSM)。利润。患者和方法:检测到预术和术后参数,包括成像数据,原发性肿瘤,生物学预后因子和佐剂方案的组织学;患者接近/阳性Retroareolar MAMGINS接受乳头或NAC切除。主要终点是基因座 - 区域复发(LRR)。结果:TND <= 2cm的患者具有明显较高的侵入性导管癌(P <0.003)和小于2mm的切除余量(P <0.000)。 Eleven Retroareolar标本在明确的病理学中为阳性;最终再切除标本检查显示7名患者的残留疾病(63.6%)。在31至33个月的中位随访中,没有发生NAC再次发生;无病生存率超过96%,并且LRR在TND亚组中均匀分布。结论:治疗性NSM是在术前乳房MRI评估的TND独立于TND的安全程序。 retroareolar组织的永久部分评估比冷冻部分更准确和成本效益。此外,延迟乳头和/或NAC切除不损害局部疾病控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号